Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022;12(s1):S93-S104.
doi: 10.3233/JPD-223228.

Age-Related Adaptive Immune Changes in Parkinson's Disease

Affiliations
Review

Age-Related Adaptive Immune Changes in Parkinson's Disease

Antonina Kouli et al. J Parkinsons Dis. 2022.

Abstract

Ageing is a major risk factor for most neurodegenerative diseases, including Parkinson's disease (PD). Progressive age-related dysregulation of the immune system is termed immunosenescence and is responsible for the weakened response to novel antigens, increased susceptibility to infections and reduced effectiveness of vaccines seen in the elderly. Immune activation, both within the brain and periphery, is heavily implicated in PD but the role of immunosenescence has not been fully explored. Studies to date provide some evidence for an attenuation in immunosenescence in PD, particularly a reduction in senescent CD8 T lymphocytes in PD cases compared to similarly aged controls. Here, we discuss recent evidence of age-related immune abnormalities in PD with a focus on T cell senescence and explore their potential role in disease pathogenesis and development.

Keywords: Parkinson’s disease; T lymphocytes; ageing; immunosenescence.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to report.

Figures

Fig. 1
Fig. 1
Schematic illustration showing a hypothesized relationship between immunosenescence and Parkinson’s disease risk/progression. With advancing age there is progressive decline in the size and function of the thymus gland (thymic involution), as well as increased exposure to viruses such as cytomegalovirus. This leads to immunosenescence, characterized by a reduction in antigen-inexperienced naïve T cells and an increase in “senescent” terminally differentiated effector T cells (TEMRA). The senescent shift is associated with a weakened immune response to novel antigens. However, in people who are predisposed to develop Parkinson’s disease, the typical age-associated shift towards senescence in the CD8 T cell population may be attenuated, with a reduced accumulation of CD8 TEMRA T cells in these individuals. This could lead to a heightened immune response to newly encountered antigens (such as misfolded alpha-synuclein), thereby increasing the risk of developing Parkinson’s and/or promoting more rapid disease progression. CMV, Cytomegalovirus; PD, Parkinson’s disease.

References

    1. Fajemiroye JO, Cunha da LC, Saavedra-Rodríguez R, Rodrigues KL, Naves LM, Mourão AA, Silva da EF, Williams NEE, Martins JLR, Sousa RB, Rebelo ACS, Reis da AA S, Santos da R S, Ferreira-Neto ML, Pedrino GR (2018) Aging-induced biological changes and cardiovascular diseases. Biomed Res Int 2018, e7156435. - PMC - PubMed
    1. Laconi E, Marongiu F, DeGregori J (2020) Cancer as a disease of old age: Changing mutational and microenvironmental landscapes. Br J Cancer 122, 943–952. - PMC - PubMed
    1. Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15, 565–581. - PubMed
    1. Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: A quantitative review. Vaccine 24, 1159–1169. - PubMed
    1. Goronzy JJ, Weyand CM (2012) Immune aging and autoimmunity. Cell Mol Life Sci 69, 1615–1623. - PMC - PubMed

Publication types